参考文献/References:
[1]DEAN L E,JONES G T,MACDONALD A G,et al.Global prevalence of ankylosing spondylitis[J].Rheumatology (Oxford),2014,53(4):650-657.
[2]VORUGANTI A,BOWNESS P.New developments in our understanding of ankylosing spondylitis pathogenesis[J].Immunology,2020,161(2):94-102.
[3]HWANG M C,RIDLEY L,REVEILLE J D.Ankylosing spondylitis risk factors:A systematic literature review[J].Clin Rheumatol,2021,40(8):3079-3093.
[4]王振东,杨娟娟,李浩林,等.强直性脊柱炎的发病机制及中药干预研究进展[J].中国实验方剂学杂志，2024,30(22):289-298.
[5]杨娟娟,李浩林,王振东,等.强直性脊柱炎的骨免疫学机制及中医药治疗的研究进展[J].中药新药与临床药理,2024,35(8):1264-71.
[6]HEIJDE D,BARALIAKOS X,SIEPER J,et al.Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy:A double-blind randomised placebo-controlled phase 3 trial[J].Ann Rheum Dis,2022,81(11):1515-1523.
[7]FENG X,YANG Q,WANG C,et al.Punicalagin exerts protective effects against ankylosing spondylitis by regulating NF-κB-TH17/JAK2/STAT3 signaling and oxidative stress[J].Biomed Res Int,2020,20:4918239.
[8]LIU K,WU L,SHI X,et al.Protective effect of naringin against ankylosing spondylitis via ossification inflammation and oxidative stress in mice[J].Exp Ther Med,2016,12(2):1153-1158.
[9]尚娟.加味愈痛丸治疗强直性脊柱炎疗效观察及对血清JAK/STAT信号通路的影响[J].新中医,2023,55(21):77-82.
[10]王莉.新加阳和汤对强直性脊柱炎模型小鼠的实验研究[J].心理月刊,2020,15(4):48，50.
[11]DING X,LIU J,SUN Y,et al.Jianpi Qingre Tongluo decoction exerted an anti-inflammatory effect on AS by inhibiting the NONHSAT227927.1/JAK2/STAT3 axis[J].Heliyon,2024,10(14):e34634.
[12]WANG X,WU L,YU M,et al.Exploring the molecular mechanism of epimedium for the treatment of ankylosing spondylitis based on network pharmacology molecular docking and molecular dynamics simulations[J].Mol Divers,2024：1-16.
[13]SONG C,WANG K,QIAN B,et al.Nrf-2/ROS/NF-κB pathway is modulated by cynarin in human mesenchymal stem cells in vitro from ankylosing spondylitis[J].Clin Transl Sci,2024,17(3):e13748.
[14]孙立明,魏芳晶.强直性脊柱炎活动期患者血瘀状态相关细胞因子/NF-κB信号通路情况及新风胶囊干预机制[J].临床骨科杂志,2017,20(1):38-41.
[15]吴琳,李松倍,苏晓庆,等.基于CX3CL1/NF-κB信号通路探讨补肾强督方抑制M1巨噬细胞极化治疗强直性脊柱炎的机制研究[J].海南医学院学报，2024，30(19):1478-1485.
[16]黄旦.CircRNA_0003307竞争性结合miR-191-5p调控CDK6/NF-κB介导强直性脊柱炎湿热证患者免疫炎症的机制及黄芩清热除痹胶囊干预研究[D].合肥：安徽中医药大学,2021.
[17]邢伟,李鹏飞,付海平,等.丹皮酚通过调节Wnt途径对强直性脊柱炎小鼠疗效及滑膜组织中RANKL和Smadl水平的影响[J].临床和实验医学杂志,2020,19(2):118-121.
[18]焦士军,李岩,韦中阳,等.黄芪总黄酮通过调节Notch-Wnt信号通路对强直性脊柱炎模型大鼠炎症反应和成纤维细胞成骨转化的影响[J].广东药科大学学报,2022,38(3):43-48.
[19]邹宇聪.从Wnt/β-catenin通路及其抑制因子Dickkopf-1与前列腺素E2的交互作用探讨雷公藤红素抗强直性脊柱炎异位骨化的机制研究[D].广州:南方医科大学，2016.
[20]李灿,刘丹,罗常春,等.壮督驱寒合剂对强直性脊柱炎模型小鼠miR-29a及Wnt信号通路的影响[J].陕西中医,2020,41(8):1038-1041.
[21]杨文雪,金玥,周童亮,等.补肾舒脊颗粒对hBMSC软骨内成骨过程中Wnt/β-catenin信号通路的影响[J].中华中医药杂志,2018,33(2):512-516.
[22]易浩.补肾强督治偻方成分分析及对强直性脊柱炎新骨形成影响的体外研究[D].广州：广州中医药大学,2021.
[23]WANG G,CAI J,ZHANG J,et al.Mechanism of triptolide in treating ankylosing spondylitis through the antiossification effect of the BMP/Smad signaling pathway[J].Mol Med Rep,2018,17(2):2731-2737.
[24]马晓娟,刘宏潇,赵哲,等.淫羊藿苷对强直性脊柱炎成纤维细胞向成骨型分化的影响[J].辽宁中医杂志,2021,48(6):186-190，258.
[25]付姣,赵哲,刘宏潇,等.丹参酮ⅡA通过影响BMP/Smad信号对强直性脊柱炎异位成骨的干预作用[J].辽宁中医杂志,2021,48(5):141-144.
[26]路占忠,刘进子,陈翠柳,等.壮骨强脊颗粒治疗强直性脊柱炎的疗效及其对TNF-α、BMP-2的影响[J].河北中医药学报,2020,35(5):11-15.
[27]张干.五味温通除痹胶囊联合中药熏蒸对AS患者BMP/Smads信号通路表达的影响[D].合肥：安徽中医药大学,2021.
[28]DING M H,XU P G,WANG Y,et al.Resveratrol attenuates ankylosing spondylitis in mice by inhibiting the TLR4/NF-κB/NLRP3 pathway and regulating gut microbiota[J].Immunol Invest,2023,52(2):194-209.
[29]赖楚儿,王义军.基于网络药理学探讨青风藤穿山龙药对治疗强直性脊柱炎的作用机制[J].特产研究,2022,44(3):43-50.
[30]杜望磊,李治琴,杨西超,等.白芍总苷治疗强直性脊柱炎临床疗效及对血清炎症因子水平的影响[J].解放军医药杂志,2019,31(1):87-91.
[31]WANG Z,DU M,LI J,et al.Clinical study of Tongdu Shujin decoction in the treatment of ankylosing spondylitis with cold-dampness obstruction type:Study protocol for a randomized controlled trial[J].Medicine (Baltimore),2023,102(6):e32852.
[32]岳海振,陈娟,王英,等.解毒除湿通督汤联合小针刀治疗湿热痹阻型强直性脊柱炎疗效及对血清CRP、IL-1β和TNF-α水平的影响[J].中华中医药学刊,2024,42(8):63-67.
[33]刘悦.TAZ活化强直性脊柱炎Th17细胞及雷公藤甲素干预机制[D].北京:中国中医科学院,2021.
[34]吴冬梅.从Hippo信号通路调控TAZ探索强直性脊柱炎Th17分化偏移及中药干预机制[D].北京:中国中医科学院,2020.
相似文献/References:
[1]郭乃亮.补肾强督治尪汤加减治疗肾虚督寒型强直性脊柱炎疗效及对患者炎症因子的影响[J].陕西中医,2019,(10):1394.
[2]时文才,聂晨旭,胡晓龙,等.黄芪桂枝五物汤合血府逐瘀汤联合针灸治疗早期强直性脊柱炎临床研究*[J].陕西中医,2020,(3):315.
[3]杜 燕,茆春阳,周 波△,等.浅论强直性脊柱炎归于肝*[J].陕西中医,2020,(4):515.
DU Yan,MAO Chunyang,ZHOU Bo,et al.On ankylosing spondylitis due to the liver[J].,2020,(7):515.
[4]李 灿,刘 丹,罗常春,等.壮督驱寒合剂对强直性脊柱炎模型小鼠miR-29a及Wnt信号通路的影响*[J].陕西中医,2020,(8):1038.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.006]
LI Can,LIU Dan,LUO Changchun,et al.Effects of Zhuangdu Quhan mixture on miR-29a and Wnt pathway in the ankylosing spondylitis model mice[J].,2020,(7):1038.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.006]
[5]王 培,柳 杨,安艳辰,等.雷火灸联合西药治疗肾虚督寒型强直性脊柱炎临床研究[J].陕西中医,2023,(6):789.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.025]
WANG Pei,LIU Yang,AN Yanchen,et al.Clinical study on thunder-fire moxibustion combined with western medicine on ankylosing spondylitis of kidney deficiency and governor meridian cold type[J].,2023,(7):789.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.025]
[6]韩 胜,邓素玲,韩小飞,等.推拿经筋手法联合温肾通督汤治疗强直性脊柱炎疗效研究[J].陕西中医,2023,(11):1628.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.033]
HAN Sheng,DENG Suling,HAN Xiaofei,et al.Curative effect study on massage manipulation combined with Wenshen Tongdu prescription for ankylosing spondylitis[J].,2023,(7):1628.[doi:DOI:10.3969/j.issn.1000-7369.2023.11.033]
[7]吴智龙,殷继超,胡兴律,等.强直性脊柱炎发病与二十四节气相关性研究[J].陕西中医,2024,(1):75.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.017]
WU Zhilong,YIN Jichao,HU Xinglv,et al.A study on the correlation between the onset of ankylosing spondylitis and the twenty-fourth festival season[J].,2024,(7):75.[doi:DOI:10.3969/j.issn.1000-7369.2024.01.017]
[8]李 吉,李引刚,刘艳平,等.名中医李彦民辨治强直性脊柱炎经验探微[J].陕西中医,2024,(7):967.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.024]
LI Ji,LI Yingang,LIU Yanping,et al.Exploration of famous traditional Chinese medicine LI Yanmin's clinical experience in treating ankylosing spondylitis[J].,2024,(7):967.[doi:DOI:10.3969/j.issn.1000-7369.2024.07.024]
[9]蒋著椿,彭佩纯,李小梅,等.基于HIF-1α/VEGF信号通路探讨瑶药肿瘤藤对HepG2肝癌细胞的效应机制[J].陕西中医,2025,46(6):723.[doi:DOI:10.3969/j.issn.1000-7369.2025.06.001]
JIANG Zhuchun,PENG Peichun,LI Xiaomei,et al.Exploring the effect mechanism of Yao medicine tumor vine on HepG2 hepatocellular carcinoma cells based on HIF-1α/VEGF signaling pathway[J].,2025,46(7):723.[doi:DOI:10.3969/j.issn.1000-7369.2025.06.001]
[10]张萌,黄倩,周长静,等.基于PI3K/AKT/GLUT4通路探讨乌葛丹丸改善2型糖尿病胰岛素抵抗作用机制[J].陕西中医,2025,46(6):734.[doi:DOI:10.3969/j.issn.1000-7369.2025.06.003]
ZHANG Meng,HUANG Qian,ZHOU Changjing,et al.Effect and mechanism of Wugedan pill on insulin resistance in type 2 diabetes mellitus based on PI3K/AKT/GLUT4 pathway[J].,2025,46(7):734.[doi:DOI:10.3969/j.issn.1000-7369.2025.06.003]